Abstract |
In the present study, we demonstrate that recombinant human secretory leukocyte protease inhibitor (rhSLPI) inhibits infection of lymphocyte- and monocyte-derived tumor cell lines and peripheral blood lymphocytes with laboratory-adapted isolates and with the primary isolate, NDK, of free human immunodeficiency virus type 1 (HIV-1). In contrast, rhSLPI did not exhibit inhibitory activity toward transcytosis of cell-associated HIV-1 through a tight monolayer of endometrial epithelial cells. These observations indicate that the inhibitory effect of SLPI is restricted to free HIV-1 in corporal fluids.
|
Authors | H Hocini, P Becquart, H Bouhlal, H Adle-Biassette, M D Kazatchkine, L Bélec |
Journal | Clinical and diagnostic laboratory immunology
(Clin Diagn Lab Immunol)
Vol. 7
Issue 3
Pg. 515-8
(May 2000)
ISSN: 1071-412X [Print] United States |
PMID | 10799472
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Proteinase Inhibitory Proteins, Secretory
- Proteins
- RNA, Messenger
- Recombinant Proteins
- SLPI protein, human
- Secretory Leukocyte Peptidase Inhibitor
- Serine Proteinase Inhibitors
|
Topics |
- Acquired Immunodeficiency Syndrome
(immunology, prevention & control, transmission)
- Cervix Uteri
(cytology, virology)
- Epithelial Cells
(drug effects, metabolism, virology)
- Female
- Gene Expression
(immunology)
- HIV Seronegativity
- HIV-1
- Humans
- Lymphocytes
(drug effects, metabolism, virology)
- Monocytes
(drug effects, metabolism, virology)
- Proteinase Inhibitory Proteins, Secretory
- Proteins
(genetics, immunology, pharmacology)
- RNA, Messenger
(analysis)
- Recombinant Proteins
(pharmacology)
- Secretory Leukocyte Peptidase Inhibitor
- Serine Proteinase Inhibitors
(immunology, pharmacology)
- Tight Junctions
(metabolism, virology)
|